40:@0.021502:0.039294:0.047607:0.039294:0.047607:0.019261:0.021502:0.019261:0.000000:0.000000
Drug-class overview:@0.097208:0.039084:0.342812:0.039084:0.342812:0.019649:0.097208:0.019649:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS :@0.097141:0.974259:0.701335:0.974259:0.701335:0.960936:0.097141:0.960936:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.701335:0.974259:0.705081:0.974259:0.705081:0.960936:0.701335:0.960936:0.000000
VOLUME 1:@0.705252:0.974259:0.786566:0.974259:0.786566:0.959690:0.705252:0.959690:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
managed medically and with percutaneous :@0.096970:0.096562:0.479970:0.096562:0.479970:0.081574:0.096970:0.081574:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
coronary intervention/coronary artery bypass :@0.096970:0.111750:0.479970:0.111750:0.479970:0.096761:0.096970:0.096761:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
graft:@0.096970:0.126937:0.132857:0.126937:0.132857:0.111948:0.096970:0.111948:0.000000:0.000000:0.000000:0.000000:0.000000
Dosage::@0.096970:0.146595:0.166396:0.146595:0.166396:0.130204:0.096970:0.130204:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
13:@0.166395:0.140815:0.178848:0.140815:0.178848:0.131259:0.166395:0.131259:0.000000:0.000000
Initiate with single 180 mg loading dose and :@0.096970:0.161791:0.479990:0.161791:0.479990:0.146803:0.096970:0.146803:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
continue at 90 mg 2 x daily.  administer with :@0.096970:0.176978:0.479970:0.176978:0.479970:0.161990:0.096970:0.161990:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
aspirin:@0.096970:0.192166:0.147673:0.192166:0.147673:0.177177:0.096970:0.177177:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
unless:@0.171803:0.192166:0.220102:0.192166:0.220102:0.177177:0.171803:0.177177:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
specifically:@0.244232:0.192166:0.327224:0.192166:0.327224:0.177177:0.244232:0.177177:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
contraindicated.:@0.351354:0.192166:0.475756:0.192166:0.475756:0.177177:0.351354:0.177177:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Initial aspirin dose to be followed by 75-150 mg :@0.096970:0.207353:0.479970:0.207353:0.479970:0.192364:0.096970:0.192364:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
maintenance dose daily. Missed dose: administer :@0.096970:0.222540:0.479970:0.222540:0.479970:0.207551:0.096970:0.207551:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
one  90 mg  tablet  (the  next  dose)  at  scheduled :@0.096970:0.237727:0.479913:0.237727:0.479913:0.222738:0.096970:0.222738:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
time   Switching patients from clopidogrel to :@0.096970:0.252914:0.479990:0.252914:0.479990:0.237925:0.096970:0.237925:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.141439:0.252398:0.150252:0.252398:0.150252:0.237714:0.141439:0.237714:0.000000
ticagrelor: administer first 90 mg ticagrelor dose :@0.096989:0.268101:0.480009:0.268101:0.480009:0.253112:0.096989:0.253112:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
24 hours following last clopidogrel dose. therapy :@0.096989:0.283288:0.479990:0.283288:0.479990:0.268299:0.096989:0.268299:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
recommended for at least 12 months unless :@0.096989:0.298475:0.479970:0.298475:0.479970:0.283486:0.096989:0.283486:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
discontinuation clinically indicated:@0.096989:0.313662:0.362707:0.313662:0.362707:0.298674:0.096989:0.298674:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Side effects: :@0.096989:0.333321:0.204092:0.333321:0.204092:0.316930:0.096989:0.316930:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Hyperuricaemia :@0.096989:0.348508:0.222911:0.348508:0.222911:0.333519:0.096989:0.333519:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.239556:0.347992:0.248369:0.347992:0.248369:0.333308:0.239556:0.333308:0.000000
 Confusion :@0.248369:0.348508:0.351854:0.348508:0.351854:0.333519:0.248369:0.333519:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.368499:0.347992:0.377312:0.347992:0.377312:0.333308:0.368499:0.333308:0.000000
 Headache :@0.377312:0.348508:0.480009:0.348508:0.480009:0.333519:0.377312:0.333519:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475795:0.348508:0.480009:0.348508:0.480009:0.333519:0.475795:0.333519:0.000000
:@0.097008:0.363179:0.105821:0.363179:0.105821:0.348495:0.097008:0.348495:0.000000
 dizziness   IC/eye haemorrhage   Paraesthesia :@0.105821:0.363695:0.480028:0.363695:0.480028:0.348706:0.105821:0.348706:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.187293:0.363179:0.196106:0.363179:0.196106:0.348495:0.187293:0.348495:0.000000
:@0.367037:0.363179:0.375850:0.363179:0.375850:0.348495:0.367037:0.348495:0.000000
 :@0.475814:0.363695:0.480028:0.363695:0.480028:0.348706:0.475814:0.348706:0.000000
:@0.097027:0.378366:0.105840:0.378366:0.105840:0.363682:0.097027:0.363682:0.000000
 vertigo   epistaxis   dyspnoea   Haemoptysis :@0.105840:0.378882:0.480028:0.378882:0.480028:0.363893:0.105840:0.363893:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.173881:0.378366:0.182694:0.378366:0.182694:0.363682:0.173881:0.363682:0.000000
:@0.260857:0.378366:0.269670:0.378366:0.269670:0.363682:0.260857:0.363682:0.000000
:@0.360571:0.378366:0.369384:0.378366:0.369384:0.363682:0.360571:0.363682:0.000000
 :@0.475814:0.378882:0.480028:0.378882:0.480028:0.363893:0.475814:0.363893:0.000000
:@0.097027:0.393553:0.105840:0.393553:0.105840:0.378869:0.097027:0.378869:0.000000
GI:@0.130009:0.394069:0.146076:0.394069:0.146076:0.379080:0.130009:0.379080:0.000000:0.000000
disorders:@0.170245:0.394069:0.240268:0.394069:0.240268:0.379080:0.170245:0.379080:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
including:@0.264436:0.394069:0.336922:0.394069:0.336922:0.379080:0.264436:0.379080:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
retroperitoneal:@0.361091:0.394069:0.475852:0.394069:0.475852:0.379080:0.361091:0.379080:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
haemorrhage :@0.097027:0.409256:0.206112:0.409256:0.206112:0.394268:0.097027:0.394268:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.224585:0.408740:0.233398:0.408740:0.233398:0.394056:0.224585:0.394056:0.000000
  Skin  disorders  including :@0.233398:0.409256:0.480009:0.409256:0.480009:0.394268:0.233398:0.394268:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
subcutaneous bleeding   Haemarthrosis   urinary :@0.097027:0.424443:0.480047:0.424443:0.480047:0.409455:0.097027:0.409455:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.281216:0.423927:0.290029:0.423927:0.290029:0.409243:0.281216:0.409243:0.000000
:@0.407985:0.423927:0.416798:0.423927:0.416798:0.409243:0.407985:0.409243:0.000000
tract bleeding   Post procedural haemorrhage  :@0.097027:0.439630:0.480028:0.439630:0.480028:0.424642:0.097027:0.424642:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.218928:0.439114:0.227741:0.439114:0.227741:0.424430:0.218928:0.424430:0.000000
:@0.097027:0.454301:0.105840:0.454301:0.105840:0.439617:0.097027:0.439617:0.000000
 other bleeding events:@0.105840:0.454817:0.282428:0.454817:0.282428:0.439829:0.105840:0.439829:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications:  :@0.097047:0.474476:0.271094:0.474554:0.271094:0.458163:0.097047:0.458085:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
13:@0.254755:0.468769:0.267208:0.468769:0.267208:0.459213:0.254755:0.459213:0.000000:0.000000
active pathological bleeding   Inherited bleeding :@0.096970:0.489741:0.479990:0.489741:0.479990:0.474752:0.096970:0.474752:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.320836:0.489225:0.329649:0.489225:0.329649:0.474540:0.320836:0.474540:0.000000
disorders   Severe hepatic impairment   IC :@0.096970:0.504928:0.479990:0.504928:0.479990:0.489939:0.096970:0.489939:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.179847:0.504412:0.188660:0.504412:0.188660:0.489728:0.179847:0.489728:0.000000
:@0.439080:0.504412:0.447893:0.504412:0.447893:0.489728:0.439080:0.489728:0.000000
haemorrhage history   Strong CYP3a4 inhibitors/:@0.096989:0.520115:0.475776:0.520115:0.475776:0.505126:0.096989:0.505126:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.263012:0.519599:0.271825:0.519599:0.271825:0.504915:0.263012:0.504915:0.000000
inducers   Safety in pregnancy/concomitant :@0.096989:0.535302:0.480028:0.535302:0.480028:0.520313:0.096989:0.520313:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.176672:0.534786:0.185485:0.534786:0.185485:0.520102:0.176672:0.520102:0.000000
warfarin not established   Safety and efficacy in :@0.097008:0.550489:0.480009:0.550489:0.480009:0.535500:0.097008:0.535500:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.292607:0.549973:0.301420:0.549973:0.301420:0.535289:0.292607:0.535289:0.000000
children below 18 years not established   no data :@0.097008:0.565676:0.480067:0.565676:0.480067:0.550688:0.097008:0.550688:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.402828:0.565160:0.411641:0.565160:0.411641:0.550476:0.402828:0.550476:0.000000
available for treatment longer than 12 months:@0.097008:0.580863:0.450607:0.580863:0.450607:0.565875:0.097008:0.565875:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Special precautions::@0.097008:0.600522:0.269439:0.600522:0.269439:0.584131:0.097008:0.584131:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
13:@0.269398:0.594766:0.281851:0.594766:0.281851:0.585210:0.269398:0.585210:0.000000:0.000000
Patients  at  risk  of  bleeding,  e.g.  recent  trauma, :@0.096970:0.615743:0.479913:0.615743:0.479913:0.600754:0.096970:0.600754:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
recent surgery, coagulation disorders, active or :@0.096970:0.630930:0.479990:0.630930:0.479990:0.615941:0.096970:0.615941:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
recent GI bleeding   Concomitant administration :@0.096970:0.646117:0.479951:0.646117:0.479951:0.631128:0.096970:0.631128:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.245021:0.645601:0.253834:0.645601:0.253834:0.630917:0.245021:0.630917:0.000000
of nSaIds, oral anticoagulants and/or fibrinolytics :@0.096970:0.661304:0.479932:0.661304:0.479932:0.646315:0.096970:0.646315:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.096970:0.675975:0.105783:0.675975:0.105783:0.661291:0.096970:0.661291:0.000000
 Surgery   Patients at risk for bradycardic events :@0.105783:0.676491:0.479951:0.676491:0.479951:0.661503:0.105783:0.661503:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.175074:0.675975:0.183887:0.675975:0.183887:0.661291:0.175074:0.661291:0.000000
 :@0.475737:0.676491:0.479951:0.676491:0.479951:0.661503:0.475737:0.661503:0.000000
:@0.096970:0.691162:0.105783:0.691162:0.105783:0.676478:0.096970:0.676478:0.000000
  asthma/CoPd    renal function monitoring :@0.105783:0.691678:0.479970:0.691678:0.479970:0.676690:0.105783:0.676690:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.239460:0.691162:0.248273:0.691162:0.248273:0.676478:0.239460:0.676478:0.000000
after 1 month and thereafter according to routine :@0.096970:0.706865:0.479932:0.706865:0.479932:0.691877:0.096970:0.691877:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
medical  practice,  paying  special  attention  to :@0.096970:0.722052:0.479932:0.722052:0.479932:0.707064:0.096970:0.707064:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
patients ≥75 years   Patients with moderate/:@0.096970:0.737240:0.475756:0.737240:0.475756:0.722251:0.096970:0.722251:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.259337:0.736724:0.268150:0.736724:0.268150:0.722039:0.259337:0.722039:0.000000
severe renal impairment and those receiving :@0.096970:0.752427:0.479970:0.752427:0.479970:0.737438:0.096970:0.737438:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
concomitant treatment with  arb :@0.096970:0.767614:0.386645:0.767614:0.386645:0.752625:0.096970:0.752625:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.397478:0.767098:0.406291:0.767098:0.406291:0.752413:0.397478:0.752413:0.000000
 History :@0.406310:0.767614:0.479970:0.767614:0.479970:0.752625:0.406310:0.752625:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475756:0.767614:0.479970:0.767614:0.479970:0.752625:0.475756:0.752625:0.000000
of hyperuricaemia or gouty arthritis   Pregnancy :@0.096970:0.782801:0.479970:0.782801:0.479970:0.767812:0.096970:0.767812:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.380064:0.782285:0.388877:0.782285:0.388877:0.767600:0.380064:0.767600:0.000000
and lactation.:@0.096970:0.797988:0.200859:0.797988:0.200859:0.782999:0.096970:0.782999:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Drug interactions::@0.096970:0.817646:0.251929:0.817646:0.251929:0.801255:0.096970:0.801255:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
13:@0.251927:0.811916:0.264379:0.811916:0.264379:0.802360:0.251927:0.802360:0.000000:0.000000
Increased digoxin/simvastatin/atorvastatin  auC :@0.096970:0.832892:0.479970:0.832892:0.479970:0.817904:0.096970:0.817904:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475756:0.832892:0.479970:0.832892:0.479970:0.817904:0.475756:0.817904:0.000000
and C  :@0.096970:0.848079:0.176344:0.848084:0.176344:0.833096:0.096970:0.833091:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
max:@0.153037:0.851111:0.172130:0.851111:0.172130:0.842372:0.153037:0.842372:0.000000:0.000000:0.000000
:@0.187716:0.847568:0.196529:0.847568:0.196529:0.832884:0.187716:0.832884:0.000000
 Increased  auC and C  with :@0.196529:0.848084:0.479977:0.848084:0.479977:0.833096:0.196529:0.833096:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
max:@0.406909:0.851111:0.426002:0.851111:0.426002:0.842372:0.406909:0.842372:0.000000:0.000000:0.000000
ketoconazole/diltiazem    decreased  auC  and :@0.096976:0.863271:0.479958:0.863271:0.479958:0.848283:0.096976:0.848283:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.288072:0.862755:0.296885:0.862755:0.296885:0.848071:0.288072:0.848071:0.000000
C  with rifampicin and other CYP3a4 inducers.:@0.096957:0.878459:0.463715:0.878468:0.463715:0.863480:0.096957:0.863470:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
max:@0.107938:0.881495:0.127031:0.881495:0.127031:0.872756:0.107938:0.872756:0.000000:0.000000:0.000000
glycoprotein iiB/iiia inhibitors:@0.096970:0.906771:0.432147:0.906771:0.432147:0.885216:0.096970:0.885216:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Glycoprotein IIb/IIIa inhibitors form a group of :@0.096970:0.921155:0.480009:0.921155:0.480009:0.906166:0.096970:0.906166:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
pharmaceutical agents that include abciximab :@0.096970:0.936646:0.479970:0.936646:0.479970:0.921657:0.096970:0.921657:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
and tirofiban and are used as potent parenteral :@0.524247:0.096567:0.907286:0.096567:0.907286:0.081579:0.524247:0.081579:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
platelet aggregation inhibitors.:@0.524247:0.112363:0.760044:0.112363:0.760044:0.097374:0.524247:0.097374:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
14:@0.760035:0.106577:0.770984:0.106577:0.770984:0.097839:0.760035:0.097839:0.000000:0.000000
Glycoprotein IIb/IIIa inhibitors block the :@0.542424:0.128161:0.907260:0.128161:0.907260:0.113173:0.542424:0.113173:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
glycoprotein IIb/IIIa receptors on the surface of :@0.524240:0.143957:0.907279:0.143957:0.907279:0.128968:0.524240:0.128968:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
platelets, preventing platelet aggregation.:@0.524240:0.159752:0.844953:0.159752:0.844953:0.144764:0.524240:0.144764:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2:@0.844949:0.153975:0.850424:0.153975:0.850424:0.145237:0.844949:0.145237:0.000000
Abciximab:@0.524242:0.188670:0.638516:0.188670:0.638516:0.167115:0.524242:0.167115:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Indications::@0.524242:0.207827:0.624629:0.207827:0.624629:0.191436:0.524242:0.191436:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
11:@0.624628:0.202043:0.637080:0.202043:0.637080:0.192487:0.624628:0.192487:0.000000:0.000000
abciximab  is  indicated  as  adjunct  therapy  to :@0.524242:0.223627:0.907185:0.223627:0.907185:0.208638:0.524242:0.208638:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
heparin and aspirin therapy for the prevention of :@0.524242:0.239422:0.907204:0.239422:0.907204:0.224434:0.524242:0.224434:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
ischaemic complications in patients undergoing :@0.524242:0.255218:0.907243:0.255218:0.907243:0.240229:0.524242:0.240229:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
PCI.  Furthermore, abciximab is indicated for :@0.524242:0.271014:0.907281:0.271025:0.907281:0.256036:0.524242:0.256025:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
11:@0.552278:0.265240:0.563227:0.265240:0.563227:0.256502:0.552278:0.256502:0.000000:0.000000
short-term MI risk reduction in unstable angina :@0.524242:0.286820:0.907242:0.286820:0.907242:0.271832:0.524242:0.271832:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
patients not responding to conventional :@0.524242:0.302616:0.907223:0.302616:0.907223:0.287627:0.524242:0.287627:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
therapeutic:@0.524242:0.318412:0.612968:0.318412:0.612968:0.303423:0.524242:0.303423:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
scheduling:@0.639042:0.318412:0.724016:0.318412:0.724016:0.303423:0.639042:0.303423:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
for:@0.750090:0.318412:0.770756:0.318412:0.770756:0.303423:0.750090:0.303423:0.000000:0.000000:0.000000
percutaneous:@0.796829:0.318412:0.903009:0.318412:0.903009:0.303423:0.796829:0.303423:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
coronary intervention.  :@0.524242:0.334207:0.709737:0.334222:0.709737:0.319233:0.524242:0.319219:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
11:@0.694574:0.328438:0.705523:0.328438:0.705523:0.319699:0.694574:0.319699:0.000000:0.000000
Dosage::@0.524240:0.354476:0.593667:0.354476:0.593667:0.338085:0.524240:0.338085:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
11:@0.593668:0.348698:0.606120:0.348698:0.606120:0.339142:0.593668:0.339142:0.000000:0.000000
adults: 0.25 mg/kg as Iv bolus followed :@0.524242:0.370281:0.907281:0.370281:0.907281:0.355293:0.524242:0.355293:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
immediately by 0.125 μg/kg/minute as a :@0.524242:0.386077:0.907223:0.386077:0.907223:0.371088:0.524242:0.371088:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
continuous infusion   Maximum dose: 10 μg/:@0.524242:0.401873:0.903048:0.401873:0.903048:0.386884:0.524242:0.386884:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.691747:0.401357:0.700560:0.401357:0.700560:0.386672:0.691747:0.386672:0.000000
minute   Stabilisation of unstable angina patients: :@0.524242:0.417668:0.907281:0.417668:0.907281:0.402680:0.524242:0.402680:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.583412:0.417152:0.592225:0.417152:0.592225:0.402468:0.583412:0.402468:0.000000
administer bolus dose followed by infusion up to :@0.524261:0.433464:0.907300:0.433464:0.907300:0.418475:0.524261:0.418475:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
24 hrs before possible intervention and conclude :@0.524261:0.449260:0.907300:0.449260:0.907300:0.434271:0.524261:0.434271:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
12 hrs thereafter   Prevention of ischaemic cardiac :@0.524261:0.465055:0.907243:0.465055:0.907243:0.450067:0.524261:0.450067:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.651492:0.464539:0.660305:0.464539:0.660305:0.449855:0.651492:0.449855:0.000000
complications  in  patients  undergoing  PCI  not :@0.524261:0.480851:0.907223:0.480851:0.907223:0.465862:0.524261:0.465862:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
currently receiving infusion:  administer bolus :@0.524261:0.496646:0.907262:0.496646:0.907262:0.481658:0.524261:0.481658:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903048:0.496646:0.907262:0.496646:0.907262:0.481658:0.903048:0.481658:0.000000
10-60 min before intervention followed by :@0.524261:0.512442:0.907262:0.512442:0.907262:0.497453:0.524261:0.497453:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
infusion for 12 hrs.:@0.524261:0.528238:0.663999:0.528238:0.663999:0.513249:0.524261:0.513249:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications::@0.524261:0.548492:0.682049:0.548492:0.682049:0.532101:0.524261:0.532101:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
11:@0.682027:0.542750:0.694480:0.542750:0.694480:0.533194:0.682027:0.533194:0.000000:0.000000
Murine:@0.524242:0.564334:0.578986:0.564334:0.578986:0.549346:0.524242:0.549346:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
monoclonal:@0.604079:0.564334:0.696654:0.564334:0.696654:0.549346:0.604079:0.549346:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
antibodies:@0.721746:0.564334:0.802622:0.564334:0.802622:0.549346:0.721746:0.549346:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
sensitivity :@0.827714:0.564334:0.907243:0.564334:0.907243:0.549346:0.827714:0.549346:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524242:0.579614:0.533055:0.579614:0.533055:0.564930:0.524242:0.564930:0.000000
  active internal bleeding   Cva history over :@0.533055:0.580130:0.907243:0.580130:0.907243:0.565141:0.533055:0.565141:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.747415:0.579614:0.756228:0.579614:0.756228:0.564930:0.747415:0.564930:0.000000
the last 2 years   Major surgery within the last :@0.524242:0.595926:0.907223:0.595926:0.907223:0.580937:0.524242:0.580937:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.654821:0.595410:0.663634:0.595410:0.663634:0.580725:0.654821:0.580725:0.000000
2 months   Intracranial or intraspinal bleeding or :@0.524242:0.611721:0.907243:0.611721:0.907243:0.596733:0.524242:0.596733:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.603540:0.611205:0.612353:0.611205:0.612353:0.596521:0.603540:0.596521:0.000000
trauma   Intracranial neoplasms   arteriovenous :@0.524242:0.627517:0.907243:0.627517:0.907243:0.612528:0.524242:0.612528:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.585125:0.627001:0.593938:0.627001:0.593938:0.612317:0.585125:0.612317:0.000000
:@0.779993:0.627001:0.788806:0.627001:0.788806:0.612317:0.779993:0.612317:0.000000
malformation or aneurysm   Known bleeding :@0.524242:0.643312:0.907223:0.643312:0.907223:0.628324:0.524242:0.628324:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.750937:0.642796:0.759750:0.642796:0.759750:0.628112:0.750937:0.628112:0.000000
diathesis    Severe  uncontrolled  hypertension :@0.524242:0.659108:0.907223:0.659108:0.907223:0.644119:0.524242:0.644119:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.604040:0.658592:0.612853:0.658592:0.612853:0.643908:0.604040:0.643908:0.000000
:@0.524242:0.674388:0.533055:0.674388:0.533055:0.659703:0.524242:0.659703:0.000000
 Pre-existing thrombocytopenia    vasculitis :@0.533055:0.674904:0.907262:0.674904:0.907262:0.659915:0.533055:0.659915:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.811358:0.674388:0.820171:0.674388:0.820171:0.659703:0.811358:0.659703:0.000000
 :@0.903048:0.674904:0.907262:0.674904:0.907262:0.659915:0.903048:0.659915:0.000000
:@0.524261:0.690183:0.533074:0.690183:0.533074:0.675499:0.524261:0.675499:0.000000
 Hypertensive or diabetic retinopathy   Severe :@0.533074:0.690699:0.907281:0.690699:0.907281:0.675711:0.533074:0.675711:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.836219:0.690183:0.845032:0.690183:0.845032:0.675499:0.836219:0.675499:0.000000
hepatic or renal failure   Pregnancy and lactation :@0.524280:0.706495:0.907281:0.706495:0.907281:0.691506:0.524280:0.691506:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.702119:0.705979:0.710932:0.705979:0.710932:0.691295:0.702119:0.691295:0.000000
:@0.524280:0.721775:0.533093:0.721775:0.533093:0.707090:0.524280:0.707090:0.000000
 Children and patients over the age of 80 years:@0.533093:0.722291:0.888751:0.722291:0.888751:0.707302:0.533093:0.707302:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Side effects::@0.524280:0.742544:0.627497:0.742544:0.627497:0.726153:0.524280:0.726153:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
11:@0.627457:0.736803:0.639909:0.736803:0.639909:0.727247:0.627457:0.727247:0.000000:0.000000
bleeding events, such as intracranial and :@0.524242:0.758387:0.907262:0.758387:0.907262:0.743398:0.524242:0.743398:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
pulmonary haemorrhage    back or chest pain  :@0.524242:0.774183:0.907243:0.774183:0.907243:0.759194:0.524242:0.759194:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.731887:0.773667:0.740700:0.773667:0.740700:0.758982:0.731887:0.758982:0.000000
:@0.524242:0.789462:0.533055:0.789462:0.533055:0.774778:0.524242:0.774778:0.000000
 Hypotension :@0.533055:0.789978:0.657592:0.789978:0.657592:0.774990:0.533055:0.774990:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.674756:0.789462:0.683569:0.789462:0.683569:0.774778:0.674756:0.774778:0.000000
  nausea and vomiting  :@0.683569:0.789978:0.907262:0.789978:0.907262:0.774990:0.683569:0.774990:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524261:0.805258:0.533074:0.805258:0.533074:0.790574:0.524261:0.790574:0.000000
 Headache   bradycardia   Fever   Puncture-site :@0.533074:0.805774:0.907281:0.805774:0.907281:0.790785:0.533074:0.790785:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.620300:0.805258:0.629113:0.805258:0.629113:0.790574:0.620300:0.790574:0.000000
:@0.727634:0.805258:0.736447:0.805258:0.736447:0.790574:0.727634:0.790574:0.000000
:@0.787266:0.805258:0.796079:0.805258:0.796079:0.790574:0.787266:0.790574:0.000000
pain or thrombocytopenia   Cardiac tamponade :@0.524280:0.821570:0.907300:0.821570:0.907300:0.806581:0.524280:0.806581:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.735927:0.821054:0.744741:0.821054:0.744741:0.806369:0.735927:0.806369:0.000000
 :@0.903086:0.821570:0.907300:0.821570:0.907300:0.806581:0.903086:0.806581:0.000000
:@0.524300:0.836849:0.533113:0.836849:0.533113:0.822165:0.524300:0.822165:0.000000
  respiratory  distress    Hypersensitivity  and :@0.533113:0.837365:0.907300:0.837365:0.907300:0.822377:0.533113:0.822377:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.716185:0.836849:0.724998:0.836849:0.724998:0.822165:0.716185:0.822165:0.000000
allergic:@0.524319:0.853161:0.578967:0.853161:0.578967:0.838172:0.524319:0.838172:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
reactions,:@0.608716:0.853161:0.681876:0.853161:0.681876:0.838172:0.608716:0.838172:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
including:@0.711624:0.853161:0.784110:0.853161:0.784110:0.838172:0.711624:0.838172:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
anaphylaxis :@0.813859:0.853161:0.907320:0.853161:0.907320:0.838172:0.813859:0.838172:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524319:0.868441:0.533132:0.868441:0.533132:0.853756:0.524319:0.853756:0.000000
 appearance of human antichimeric antibody at :@0.533132:0.868956:0.907358:0.868956:0.907358:0.853968:0.533132:0.853968:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
low titre:@0.524319:0.884752:0.587357:0.884752:0.587357:0.869763:0.524319:0.869763:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Special precautions::@0.524319:0.905006:0.696750:0.905006:0.696750:0.888615:0.524319:0.888615:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
11:@0.696670:0.899258:0.709123:0.899258:0.709123:0.889702:0.696670:0.889702:0.000000:0.000000
Potential bleeding sites   Pre-treatment with :@0.524242:0.920841:0.907223:0.920841:0.907223:0.905853:0.524242:0.905853:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.729404:0.920325:0.738217:0.920325:0.738217:0.905641:0.729404:0.905641:0.000000
H2-receptor blocker or liquid antacid   Possible :@0.524242:0.936637:0.907262:0.936637:0.907262:0.921648:0.524242:0.921648:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.825251:0.936121:0.834064:0.936121:0.834064:0.921437:0.825251:0.921437:0.000000